Related Experiment Video
Updated: May 30, 2026

09:12
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
15.8K
Modulating neuroinflammation and cognitive function in postoperative cognitive dysfunction via CCR5-GPCRs-Ras-MAPK
Zheng Qi1, Junlin Peng1, Haitao Wang1
1Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
CNS Neuroscience & Therapeutics
|August 15, 2024
Summary
Extracellular vesicles (EVs) from microglia with C-C chemokine receptor type 5 (CCR5) worsen postoperative cognitive dysfunction (POCD). Modifying these EVs to reduce CCR5 protects against POCD, offering a new therapeutic strategy.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Postoperative cognitive dysfunction (POCD) is a common and serious condition affecting elderly patients after surgery.
- Microglia play a critical role in neuroinflammation and neuronal integrity, processes implicated in POCD.
- Extracellular vesicles (EVs) are emerging as key mediators of intercellular communication in the central nervous system.
Purpose of the Study:
- To investigate the role of C-C chemokine receptor type 5 (CCR5) on microglial extracellular vesicles (EVs) in the pathogenesis of POCD.
- To determine how EVs derived from BV2 microglial cells with or without CCR5 influence neuroinflammation, neuronal integrity, and cognitive function in a POCD mouse model.
Main Methods:
- EVs were collected from BV2 microglial cells expressing CCR5 (EVsM1) and from BV2 cells with CCR5 knockdown (EVsM1-CCR5).
- These EVs were administered to mice subjected to POCD induction.
- Protein interactions, neuroinflammation markers, synaptic protein expression, dendritic spine morphology, and cognitive function (Morris Water Maze) were assessed.
Main Results:
- Interactions between CCR5, G-protein-coupled receptors (GPCRs), and Ras were confirmed, implicating the CCR5-GPCRs-Ras-MAPK pathway in neuroinflammation.
- EVsM1 exacerbated neuroinflammation, reduced synaptic integrity, and impaired cognitive function in POCD mice.
- Conversely, EVsM1-CCR5 attenuated neuroinflammation, preserved synaptic proteins and dendritic spines, and improved cognitive performance.
Conclusions:
- Microglial EVs mediate neuroinflammation and cognitive decline in POCD through the CCR5-GPCRs-Ras-MAPK pathway.
- Reducing CCR5 expression on microglial EVs confers neuroprotection and ameliorates POCD.
- Targeted modification of microglial EVs represents a promising therapeutic avenue for managing POCD.

